Guideline-directed medical therapy (GDMT) reduces mortality and hospitalizations in adults with heart failure with reduced ejection fraction (HFrEF); however, few are receiving GDMT. National registries show as few as 1% of patients are receiving appropriate GDMT. Development of heart failure clinics achieving optimal GDMT are crucial to improve outcomes for HFrEF patients.
We developed a multidisciplinary HF-Optimize clinic aimed at improving GDMT use along with providing education, resources, and comorbidity screening for adults with HFrEF.
We targeted patients with newly diagnosed HFrEF and/or recent or multiple admissions for 6 visits over 12 weeks. We measured medication use, ejection fraction, 6-minute walk test distance, and health-related quality of life (EuroQol Visual Analog Scale) at visits 1 and 6.
One-hundred ten patients completed all visits. Patients were a mean age of 58 (±14) years, 37% were female, and 42% were of non-White race. From visit 1 to visit 6, utilization of GDMT increased from 35.5% to 85.5% (p < 0.001) and significant improvements in ejection fraction (25.9% to 35.5%, p < 0.001), 6-minute walk distance (1032 feet to 1121.7 feet, p = 0.001), and quality of life (63.8/100 vs 70.8/100, p = 0.002). Only 2 patients (1.8%) that completed HF-Optimize had a 30-day heart failure readmission.
Our multidisciplinary HF-Optimize clinic improved medication usage and clinical outcomes. Further studies are needed to validate outcomes of multidisciplinary GDMT clinics.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute Care
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Heart Disease and Stroke Statistics-2020 update: a report from the American Heart Association.Circulation. 2020; 141: e139-e596
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013; 62: e147-e239
- 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.J Am Coll Cardiol. 2017; 70: 776-803
- Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry.J Am Coll Cardiol. 2018; 72: 351-366
- Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry.JACC Heart Fail. 2019; 7: 350-358
- Effect of a hospital and postdischarge quality improvement intervention on clinical outcomes and quality of care for patients with heart failure with reduced ejection fraction: the CONNECT-HF randomized clinical trial.JAMA. 2021; 326: 314-323
- Implementing nonphysician provider guideline-directed medical therapy heart failure clinics: a multi-national imperative.J Card Fail. 2021; 27: 896-906
- Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.Int J Cardiol Heart Vasc. 2019; 22: 1-5
- Nurse-led titration of angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers in patients with heart failure with reduced ejection fraction.JAMA Cardiol. 2016; 1: 842-843
- Establishing the first pharmacist-led heart failure medication optimization clinic in the Middle East Gulf Region.JACCP: J Am Coll Clin Pharm. 2020; 3: 877-884
- Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial.Eur J Heart Fail. 2019; 21: 1012-1021
- STOP questionnaire: a tool to screen patients for obstructive sleep apnea.Anesthesiology. 2008; 108: 812-821
- The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure.Chest. 1996; 110: 325-332
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.Qual Life Res. 2013; 22: 1717-1727
- EuroQol: the current state of play.Health Policy. 1996; 37: 53-72
- Angiotensin-neprilysin inhibition versus enalapril in heart failure.N Engl J Med. 2014; 371: 993-1004
- The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.N Engl J Med. 1999; 341: 709-717
- 6-Minute walking test: a useful tool in the management of heart failure patients.Ther Adv Cardiovasc Dis. 2019; 131753944719870084
- Reliability, construct validity and determinants of 6-minute walk test performance in patients with chronic heart failure.Int J Cardiol. 2017; 240: 285-290
- A review of health utilities using the EQ-5D in studies of cardiovascular disease.Health Qual Life Outcomes. 2010; 8: 13
- Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5L.BMC Public Health. 2019; 19: 1464
- Remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.JAMA Cardiol. 2020; 5: 1430-1434
- Understanding the complexity of heart failure risk and treatment in black patients.Circ Heart Fail. 2020; 13e007264
- The crucial role of patient education in heart failure.Eur J Heart Fail. 2005; 7: 363-369
- Individualized nutritional support for hospitalized patients with chronic heart failure.J Am Coll Cardiol. 2021; 77: 2307-2319
- Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the Heart Failure Society of America Scientific Statements Committee.J Card Fail. 2019; 25: 380-400
- Sleep apnea and heart failure: part I: obstructive sleep apnea.Circulation. 2003; 107: 1671-1678
- Mechanisms of heart failure in obesity.Obes Res Clin Pract. 2014; 8: e540-e548
- The role of cardiac rehabilitation in improving cardiovascular outcomes.Nat Rev Cardiol. 2021;
- Multidisciplinary cardiac rehabilitation and long-term prognosis in patients with heart failure.Circ Heart Fail. 2020; 13e006798
Published online: September 08, 2022
Accepted: August 20, 2022
Received in revised form: July 26, 2022
Received: April 15, 2022
© 2022 Elsevier Inc. All rights reserved.